Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial (Q42646839)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial |
scientific article |
Statements
1 reference
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial (English)
1 reference
Dirk J van Veldhuisen
1 reference
Adriaan A Voors
1 reference
Suzan Willemsen
1 reference
Jasper W L Hartog
1 reference
Yoran M Hummel
1 reference
Jan L Posma
1 reference
Leen M van Wijk
1 reference
25 January 2010
1 reference
1 reference
12
1 reference
3
1 reference
294-300
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference